Citação norma APA

Nash, P., McInnes, I. B., Mease, P. J., Thom, H., Hunger, M., Karabis, A., . . . Jugl, S. M. (2018). Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect Comparison. Rheumatol Ther.

Citação norma Chicago

Nash, Peter, Iain B. McInnes, Philip J. Mease, Howard Thom, Matthias Hunger, Andreas Karabis, Kunal Gandhi, Shephard Mpofu, and Steffen M. Jugl. "Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness Up to 48 Weeks Using a Matching-Adjusted Indirect Comparison." Rheumatol Ther 2018.

Citação norma MLA

Nash, Peter, et al. "Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness Up to 48 Weeks Using a Matching-Adjusted Indirect Comparison." Rheumatol Ther 2018.

Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.